Stefan Pool

mTOR Inhibitor RAD001 Promotes Metastasis in a Rat Model of Pancreatic Neuroendocrine Cancer

Stefan Pool, Sander Bison, Stuart Koelewijn et al. · Cancer Research · 2012 · 45 citations · Full text

Chemoprevention Strategy, Immunology, Pathology +17

Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World

Cole B. Hirschfeld, Leslee J. Shaw, Michelle C. Williams et al. · JACC. Cardiovascular imaging · 2021 · 38 citations · Full text

Preventive Medicine, Cardiovascular Epidemiology, Cardiovascular Disease +11

[ ¹¹¹ In-DTPA]octreotide Tumor Uptake in GEPNET Liver Metastases After Intra-Arterial Administration: An Overview of Preclinical and Clinical Observations and Implications for Tumor Radiation Dose After Peptide Radionuclide Therapy

Stefan Pool, Boen L.R. Kam, Gerben A. Koning et al. · Cancer Biotherapy and Radiopharmaceuticals · 2014 · 28 citations · Full text

Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts

Costanza Santini, Joeri Kuil, Anton Bunschoten et al. · Journal of Nuclear Medicine · 2016 · 25 citations · Full text

Peptide receptor radionuclide therapy (PRRT) with [177Lu-DOTA0,Tyr3]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model

Sander Bison, Stefan Pool, Stuart Koelewijn et al. · EJNMMI Research · 2014 · 19 citations · Full text